KPV.
About KPV
KPV is studied in tissue regeneration and repair research, including cell and animal models. Unlike full-length alpha-MSH, KPV does not bind melanocortin receptors. Uptake instead occurs via the PepT1 transporter, with NF-kB pathway inhibition described as the target mechanism.
Research Application
Studied in inflammation biology research, particularly in gut inflammation models, based on its described NF-kB inhibition. All evidence to date is preclinical — no published human studies exist.
Important to know
Claims circulating online are often not backed by valid clinical data. Treat all information as a starting point for your own scientific research, not as usage guidance.
Sequence and regulatory status data are based on publicly available sources and refer to the compound in general, not to a specific product.
Research Overview
Studies on regenerative peptides are mostly derived from cell culture and animal models; comprehensive clinical data is typically still limited.
- Dalmasso G, et al. Gastroenterology. 2008;134(1):166–178. PMID 18061177
- Xiao B, et al. Molecular Therapy. 2017;25(7):1628–1640. PMID 28624258
- Brzoska T, et al. Endocrine Reviews. 2008;29(5):581–602. PMID 18612139
References without a PMID can be located via the respective publisher. This overview does not claim to be exhaustive.
Question about KPV?
We reply personally – via email or Telegram.